Lipid raft- and src family kinase-dependent entry of coxsackievirus B into human placental trophoblasts

Journal of Virology

Volumn 87, Issue 15, 2013, Pages 8569-8581

  Delorme Axford, Elizabeth ^a   Sadovsky, Yoel ^a,b   Coyne, Coyne ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAVEOLIN 1; CLATHRIN; DECAY ACCELERATING FACTOR; DYNAMIN II; PROTEIN TYROSINE KINASE;

ARTICLE; CELL MEMBRANE DEPOLARIZATION; CONTROLLED STUDY; COXSACKIE VIRUS B; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; INTESTINE EPITHELIUM CELL; LIPID RAFT; NONHUMAN; PINOCYTOSIS; PRIORITY JOURNAL; SURFACE PROPERTY; TIGHT JUNCTION; TROPHOBLAST; VIRUS CELL INTERACTION; VIRUS ENTRY;

ANTIGENS, CD55; CELLS, CULTURED; ENTEROVIRUS B, HUMAN; FEMALE; HUMANS; MEMBRANE MICRODOMAINS; PLACENTA; PREGNANCY; RECEPTORS, VIRUS; SRC-FAMILY KINASES; TROPHOBLASTS; VIRUS INTERNALIZATION;

EID: 84880585741     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00708-13     Document Type: Article

References (94)

1. Pallansch M, Roos RP. 2001. Enteroviruses: polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
2. Huber S, Ramsingh AI. 2004. Coxsackievirus-induced pancreatitis. Viral Immunol. 17:358-369.
3. Bergelson JM, Cunningham JA, Droguett G, Kurt-Jones EA, Krithivas A, Hong JS, Horwitz MS, Crowell RL, Finberg RW. 1997. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 275:1320-1323.
4. Martino TA, Petric M, Weingartl H, Bergelson JM, Opavsky MA, Richardson CD, Modlin JF, Finberg RW, Kain KC, Willis N, Gauntt CJ, Liu PP. 2000. The coxsackie-adenovirus receptor (CAR) is used by reference strains and clinical isolates representing all six serotypes of coxsackievirus group B and by swine vesicular disease virus. Virology 271:99-108.
5. Cohen CJ, Shieh JT, Pickles RJ, Okegawa T, Hsieh JT, Bergelson JM. 2001. The coxsackievirus and adenovirus receptor is a transmembrane component of the tight junction. Proc. Natl. Acad. Sci. U. S. A. 98:15191-15196.
6. Coyne CB, Bergelson JM. 2006. Virus-induced Abl and Fyn kinase signals permit coxsackievirus entry through epithelial tight junctions. Cell 124: 119-131.
7. Bergelson JM, Modlin JF, Wieland-Alter W, Cunningham JA, Crowell RL, Finberg RW. 1997. Clinical coxsackievirus B isolates differ from laboratory strains in their interaction with two cell surface receptors. J. Infect. Dis. 175:697-700.
8. Shafren DR, Bates RC, Agrez MV, Herd RL, Burns GF, Barry RD. 1995. Coxsackieviruses B1, B3, and B5 use decay accelerating factor as a receptor for cell attachment. J. Virol. 69:3873-3877.
9. Shieh JT, Bergelson JM. 2002. Interaction with decay-accelerating factor facilitates coxsackievirus B infection of polarized epithelial cells. J. Virol. 76:9474-9480.
10. Shafren DR, Williams DT, Barry RD. 1997. A decay-accelerating factorbinding strain of coxsackievirus B3 requires the coxsackievirusadenovirus receptor protein to mediate lytic infection of rhabdomyosarcoma cells. J. Virol. 71:9844-9848.
11. Coyne CB, Shen L, Turner JR, Bergelson JM. 2007. Coxsackievirus entry across epithelial tight junctions requires occludin and the small GTPases Rab34 and Rab5. Cell Host Microbe 2:181-192.
12. Milstone AM, Petrella J, Sanchez MD, Mahmud M, Whitbeck JC, Bergelson JM. 2005. Interaction with coxsackievirus and adenovirus receptor, but not with decay-accelerating factor (DAF), induces A-particle formation in a DAF-binding coxsackievirus B3 isolate. J. Virol. 79:655-660.
13. Bozym RA, Morosky SA, Kim KS, Cherry S, Coyne CB. 2010. Release of intracellular calcium stores facilitates coxsackievirus entry into polarized endothelial cells. PLoS Pathog. 6:e1001135. doi:10.1371/journal.ppat.1001135.
14. Patel KP, Coyne CB, Bergelson JM. 2009. Dynamin- and lipid raftdependent entry of DAF-binding and non-DAF-binding coxsackieviruses into non-polarized cells. J. Virol. 83:11064-11077.
15. Sauerbrei A, Gluck B, Jung K, Bittrich H, Wutzler P. 2000. Congenital skin lesions caused by intrauterine infection with coxsackievirus B3. Infection 28:326-328.
16. Elfving M, Svensson J, Oikarinen S, Jonsson B, Olofsson P, Sundkvist G, Lindberg B, Lernmark A, Hyoty H, Ivarsson SA. 2008. Maternal enterovirus infection during pregnancy as a risk factor in offspring diagnosed with type 1 diabetes between 15 and 30 years of age. Exp. Diabetes Res. 2008:271958. doi:10.1155/2008/271958.
17. Dahlquist G, Frisk G, Ivarsson SA, Svanberg L, Forsgren M, Diderholm H. 1995. Indications that maternal coxsackie B virus infection during pregnancy is a risk factor for childhood-onset IDDM. Diabetologia 38: 1371-1373.
18. Svensson J, Lindberg B, Jonsson B, Ericsson UB, Olofsson P, Hyoty H, Ivarsson SA. 2004. Intrauterine exposure to maternal enterovirus infection as a risk factor for development of autoimmune thyroiditis during childhood and adolescence. Thyroid 14:367-370.
19. Ouellet A, Sherlock R, Toye B, Fung KF. 2004. Antenatal diagnosis of intrauterine infection with coxsackievirus B3 associated with live birth. Infect. Dis. Obstet. Gynecol. 12:23-26.
20. Verma NA, Zheng XT, Harris MU, Cadichon SB, Melin-Aldana H, Khetsuriani N, Oberste MS, Shulman ST. 2009. Outbreak of lifethreatening coxsackievirus B1 myocarditis in neonates. Clin. Infect. Dis. 49:759-763.
21. Lu JC, Koay KW, Ramers CB, Milazzo AS. 2005. Neonate with coxsackie B1 infection, cardiomyopathy and arrhythmias. J. Natl. Med. Assoc. 97: 1028-1030.
22. Bendig JW, Franklin OM, Hebden AK, Backhouse PJ, Clewley JP, Goldman AP, Piggott N. 2003. Coxsackievirus B3 sequences in the blood of a neonate with congenital myocarditis, plus serological evidence of maternal infection. J. Med. Virol. 70:606-609.
23. Konstantinidou A, Anninos H, Spanakis N, Kotsiakis X, Syridou G, Tsakris A, Patsouris E. 2007. Transplacental infection of coxsackievirus B3 pathological findings in the fetus. J. Med. Virol. 79:754-757.
24. Euscher E, Davis J, Holzman I, Nuovo GJ. 2001. Coxsackie virus infection of the placenta associated with neurodevelopmental delays in the newborn. Obstet. Gynecol. 98:1019-1026.
25. Strong BS, Young SA. 1995. Intrauterine coxsackie virus, group B type 1, infection: viral cultivation from amniotic fluid in the third trimester. Am. J. Perinatol. 12:78-79.
26. Axelsson C, Bondestam K, Frisk G, Bergstrom S, Diderholm H.1993.Coxsackie B virus infections in women with miscarriage.J. Med. Virol.39:282-285.
27. McClure EM, Goldenberg RL.2009.Infection and stillbirth.Semin. Fetal Neonatal Med.14:182-189.
28. Satosar A, Ramirez NC, Bartholomew D, Davis J, Nuovo GJ.2004.Histologic correlates of viral and bacterial infection of the placenta associated with severe morbidity and mortality in the newborn.Hum. Pathol.35:536-545.
29. Robbins JR, Skrzypczynska KM, Zeldovich VB, Kapidzic M, Bakardjiev AI. 2010. Placental syncytiotrophoblast constitutes a major barrier to vertical transmission of Listeria monocytogenes. PLoS Pathog. 6:e1000732. doi:10.1371/journal.ppat.1000732.
30. Zeldovich VB, Robbins JR, Kapidzic M, Lauer P, Bakardjiev AI. 2011. Invasive extravillous trophoblasts restrict intracellular growth and spread of Listeria monocytogenes. PLoS Pathog. 7:e1002005. doi:10.1371/journal .ppat.1002005.
31. Robbins JR, Zeldovich VB, Poukchanski A, Boothroyd JC, Bakardjiev AI.2012.Tissue barriers of the human placenta to infection with Toxoplasma gondii.Infect. Immun.80:418-428.
32. Robbins JR, Bakardjiev AI.2012.Pathogens and the placental fortress.Curr. Opin. Microbiol.15:36-43.
33. Nelson DM, Johnson RD, Smith SD, Anteby EY, Sadovsky Y.1999.Hypoxia limits differentiation and up-regulates expression and activity of prostaglandin H synthase 2 in cultured trophoblast from term human placenta.Am. J. Obstet. Gynecol.180:896-902.
34. Kliman HJ, Nestler JE, Sermasi E, Sanger JM, Strauss JF, 3rd. 1986. Purification, characterization, and in vitro differentiation of cytotrophoblasts from human term placentae. Endocrinology 118:1567-1582.
35. Chen B, Nelson DM, Sadovsky Y.2006.N-myc down-regulated gene 1 modulates the response of term human trophoblasts to hypoxic injury.J. Biol. Chem.281:2764-2772.
36. Bozym RA, Delorme-Axford E, Harris K, Morosky S, Ikizler M, Dermody TS, Sarkar SN, Coyne CB. 2012. Focal adhesion kinase is a component of antiviral RIG-I-like receptor signaling. Cell Host. Microbe 11:153-166.
37. Brandenburg B, Lee LY, Lakadamyali M, Rust MJ, Zhuang X, Hogle JM. 2007. Imaging poliovirus entry in live cells. PLoS Biol. 5:e183. doi:10 .1371/journal.pbio.0050183.
38. Kim C, Bergelson JM. 2012. Echovirus 7 entry into polarized intestinal epithelial cells requires clathrin and Rab7. mBio 3:e00304 -11. doi:10.1128 /mBio.00304-11.
39. Gao W, Kang JH, Liao Y, Ding WX, Gambotto AA, Watkins SC, Liu YJ, Stolz DB, Yin XM.2010.Biochemical isolation and characterization of the tubulovesicular LC3-positive autophagosomal compartment.J. Biol. Chem.285:1371-1383.
40. Bergelson JM, Chan M, Solomon KR, St John NF, Lin H, Finberg RW.1994.Decay-accelerating factor (CD55), a glycosylphosphatidylinositolanchored complement regulatory protein, is a receptor for several echoviruses.Proc. Natl. Acad. Sci. U. S. A.91:6245-6248.
41. Kirchhausen T, Macia E, Pelish HE.2008.Use of dynasore, the small molecule inhibitor of dynamin, in the regulation of endocytosis.Methods Enzymol.438:77-93.
42. Smart EJ, Anderson RG.2002.Alterations in membrane cholesterol that affect structure and function of caveolae.Methods Enzymol.353:131-139.
43. Coyne CB, Kim KS, Bergelson JM.2007.Poliovirus entry into human brain microvascular cells requires receptor-induced activation of SHP-2.EMBO J.26:4016-4028.
44. Cerneus DP, van der Ende A.1991.Apical and basolateral transferrin receptors in polarized BeWo cells recycle through separate endosomes.J. Cell Biol.114:1149-1158.
45. Liu F, Soares MJ, Audus KL. 1997. Permeability properties of monolayers of the human trophoblast cell line BeWo. Am. J. Physiol. 273:C1596-1604.
46. Schlegel A, Giddings TH, Jr, Ladinsky MS, Kirkegaard K.1996.Cellular origin and ultrastructure of membranes induced during poliovirus infection.J. Virol.70:6576-6588.
47. Kemball CC, Alirezaei M, Flynn CT, Wood MR, Harkins S, Kiosses WB, Whitton JL.2010.Coxsackievirus infection induces autophagy-like vesicles and megaphagosomes in pancreatic acinar cells in vivo.J. Virol.84:12110-12124.
48. Pan J, Narayanan B, Shah S, Yoder JD, Cifuente JO, Hafenstein S, Bergelson JM. 2011. Single amino acid changes in the virus capsid permit coxsackievirus B3 to bind decay-accelerating factor. J. Virol. 85:7436-7443.
49. Crowther D, Melnick JL. 1961. The incorporation of neutral red and acridine orange into developing poliovirus particles making them photosensitive. Virology 14:11-21.
50. Wilson JN, Cooper PD. 1963. Aspects of the growth of poliovirus as revealed by the photodynamic effects of neutral red and acridine orange. Virology 21:135-145.
51. Wang LH, Rothberg KG, Anderson RG.1993.Mis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation.J. Cell Biol.123:1107-1117.
52. Ivanov AI.2008.Pharmacological inhibition of endocytic pathways: is it specific enough to be useful? Methods Mol.Biol.440:15-33.
53. Schlegel R, Dickson RB, Willingham MC, Pastan IH.1982.Amantadine and dansylcadaverine inhibit vesicular stomatitis virus uptake and receptor- mediated endocytosis of alpha 2-macroglobulin.Proc. Natl. Acad. Sci. U. S. A.79:2291-2295.
54. Johannsdottir HK, Mancini R, Kartenbeck J, Amato L, Helenius A.2009.Host cell factors and functions involved in vesicular stomatitis virus entry.J. Virol.83:440-453.
55. Sun X, Yau VK, Briggs BJ, Whittaker GR. 2005. Role of clathrinmediated endocytosis during vesicular stomatitis virus entry into host cells. Virology 338:53-60.
56. Tebar F, Sorkina T, Sorkin A, Ericsson M, Kirchhausen T.1996.Eps15 is a component of clathrin-coated pits and vesicles and is located at the rim of coated pits.J. Biol. Chem.271:28727-28730.
57. Damke H, Baba T, Warnock DE, Schmid SL.1994.Induction of mutant dynamin specifically blocks endocytic coated vesicle formation.J. Cell Biol.127:915-934.
58. Henley JR, Krueger EW, Oswald BJ, McNiven MA.1998.Dynaminmediated internalization of caveolae.J. Cell Biol.141:85-99.
59. Oh P, McIntosh DP, Schnitzer JE.1998.Dynamin at the neck of caveolae mediates their budding to form transport vesicles by GTP-driven fission from the plasma membrane of endothelium.J. Cell Biol.141:101-114.
60. Macia E, Ehrlich M, Massol R, Boucrot E, Brunner C, Kirchhausen T. 2006. Dynasore, a cell-permeable inhibitor of dynamin. Dev. Cell 10:839- 850.
61. van der Bliek AM, Redelmeier TE, Damke H, Tisdale EJ, Meyerowitz EM, Schmid SL.1993.Mutations in human dynamin block an intermediate stage in coated vesicle formation.J. Cell Biol.122:553-563.
62. Kiss AL.2012.Caveolae and the regulation of endocytosis.Adv. Exp. Med. Biol.729:14-28.
63. Mercer J, Schelhaas M, Helenius A.2010.Virus entry by endocytosis.Annu. Rev. Biochem.79:803-833.
64. Mercer J, Helenius A.2012.Gulping rather than sipping: macropinocytosis as a way of virus entry.Curr. Opin. Microbiol.15:490-499.
65. West MA, Bretscher MS, Watts C.1989.Distinct endocytotic pathways in epidermal growth factor-stimulated human carcinoma A431 cells.J. Cell Biol.109:2731-2739.
66. Meier O, Boucke K, Hammer SV, Keller S, Stidwill RP, Hemmi S,Greber UF. 2002. Adenovirus triggers macropinocytosis and endosomal leakage together with its clathrin-mediated uptake. J. Cell Biol. 158:1119-1131.
67. Koivusalo M, Welch C, Hayashi H, Scott CC, Kim M, Alexander T, Touret N, Hahn KM, Grinstein S.2010.Amiloride inhibits macropinocytosis by lowering submembranous pH and preventing Rac1 and Cdc42 signaling.J. Cell Biol.188:547-563.
68. Gschwendt M, Muller HJ, Kielbassa K, Zang R, Kittstein W, Rincke G, Marks F.1994.Rottlerin, a novel protein kinase inhibitor.Biochem. Biophys. Res. Commun.199:93-98.
69. Sarkar K, Kruhlak MJ, Erlandsen SL, Shaw S. 2005. Selective inhibition by rottlerin of macropinocytosis in monocyte-derived dendritic cells. Immunology 116:513-524.
70. Swanson JA.2008.Shaping cups into phagosomes and macropinosomes.Nat. Rev. Mol. Cell Biol.9:639-649.
71. Peterson JR, Mitchison TJ.2002.Small molecules, big impact: a history of chemical inhibitors and the cytoskeleton.Chem. Biol.9:1275-1285.
72. Coue M, Brenner SL, Spector I, Korn ED.1987.Inhibition of actin polymerization by latrunculin A.FEBS Lett.213:316-318.
73. Just I, Richter HP, Prepens U, von Eichel-Streiber C, Aktories K.1994.Probing the action of Clostridium difficile toxin B in Xenopus laevis oocytes.J. Cell Sci.107:1653-1659.
74. Just I, Fritz G, Aktories K, Giry M, Popoff MR, Boquet P, Hegenbarth S, von Eichel-Streiber C.1994.Clostridium difficile toxin B acts on the GTP-binding protein Rho.J. Biol. Chem.269:10706-10712.
75. Spiering D, Hodgson L.2011.Dynamics of the Rho-family small GTPases in actin regulation and motility.Cell Adh. Migr.5:170-180.
76. Delorme-Axford E, Coyne CB. 2011. The actin cytoskeleton as a barrier to virus infection of polarized epithelial cells. Viruses 3:2462-2477.
77. Keller HU. 1990. Diacylglycerols and PMA are particularly effective stimulators of fluid pinocytosis in human neutrophils. J. Cell. Physiol. 145: 465-471.
78. Keller HU, Niggli V, Zimmermann A.1989.Diacylglycerols and PMA induce actin polymerization and distinct shape changes in lymphocytes: relation to fluid pinocytosis and locomotion.J. Cell Sci.93:457-465.
79. Tatton L, Morley GM, Chopra R, Khwaja A.2003.The Src-selective kinase inhibitor PP1 also inhibits Kit and Bcr-Abl tyrosine kinases.J. Biol. Chem.278:4847-4853.
80. Hanke JH, Gardner JP, Dow RL, Changelian PS, Brissette WH, Weringer EJ, Pollok BA, Connelly PA.1996.Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor.Study of Lck- and FynTdependent T cell activation. J. Biol. Chem.271:695-701.
81. Wilson MB, Schreiner SJ, Choi HJ, Kamens J, Smithgall TE. 2002. Selective pyrrolo-pyrimidine inhibitors reveal a necessary role for Src family kinases in Bcr-Abl signal transduction and oncogenesis. Oncogene 21: 8075-8088.
82. Thomas SM, Brugge JS.1997.Cellular functions regulated by Src family kinases.Annu. Rev. Cell Dev. Biol.13:513-609.
83. Hatakeyama S, Iwabuchi K, Ogasawara K, Good RA, Onoe K.1994.The murine c-fgr gene product associated with Ly6C and p70 integral membrane protein is expressed in cells of a monocyte/macrophage lineage.Proc. Natl. Acad. Sci. U. S. A.91:3458-3462.
84. Katagiri K, Katagiri T, Koyama Y, Morikawa M, Yamamoto T, Yoshida T.1991.Expression of src family genes during monocytic differentiation of HL-60 cells.J. Immunol.146:701-707.
85. Ziegler SF, Wilson CB, Perlmutter RM.1988.Augmented expression of a myeloid-specific protein tyrosine kinase gene (hck) after macrophage activation.J. Exp. Med.168:1801-1810.
86. Pattillo RA, Gey GO, Delfs E, Mattingly RF. 1968. Human hormone production in vitro. Science 159:1467-1469.
87. Pattillo RA, Gey GO. 1968. The establishment of a cell line of human hormone-synthesizing trophoblastic cells in vitro. Cancer Res. 28:1231-1236.
88. Schelhaas M, Shah B, Holzer M, Blattmann P, Kuhling L, Day PM, Schiller JT, Helenius A. 2012. Entry of human papillomavirus type 16 by actin-dependent, clathrin- and lipid raft-independent endocytosis. PLoS Pathog. 8:e1002657. doi:10.1371/journal.ppat.1002657.
89. Godoy V, Riquelme G.2008.Distinct lipid rafts in subdomains from human placental apical syncytiotrophoblast membranes.J. Membr. Biol.224:21-31.
90. Vidricaire G, Tremblay MJ.2007.A clathrin, caveolae, and dynaminindependent endocytic pathway requiring free membrane cholesterol drives HIV-1 internalization and infection in polarized trophoblastic cells.J. Mol. Biol.368:1267-1283.
91. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, Shibuya M, Fukami Y.1987.Genistein, a specific inhibitor of tyrosinespecific protein kinases.J. Biol. Chem.262:5592-5595.
92. Davitz MA, Low MG, Nussenzweig V.1986.Release of decayaccelerating factor (DAF) from the cell membrane by phosphatidylinositol- specific phospholipase C (PIPLC).Selective modification of a complement regulatory protein. J. Exp. Med.163:1150-1161.
93. Van Laethem F, Leo O.2002.Membrane lipid rafts: new targets for immunoregulation.Curr. Mol. Med.2:557-570.